Similar Articles
Alternative electric tumor treatment areas in glioblastoma multiforme treatment: Rationale, preclinical and clinical studies
Ayşe Uyanık, Yusuf Bahap, Alpcan Ateş, Elif Özge Doğan, Oytun Erbaş
DOI: 10.5606/fng.btd.2017.027
Issue: 2017, Volume 3 - Issue 4
0
4951
Current trends in Glioblastoma
Mihrican Koçak, Özüm Atasoy, Nilsu Çini, Oytun Erbaş
DOI: 10.5606/fng.btd.2021.25074
Issue: 2021, Volume 7 - Issue 3
10806
2792
Glioblastoma multiforme: Subtypes based on IDH, ATRX, H3F3A, MGMT and p53 mutations
Fatime Akgeyik, Alper Demirezen, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.144
Issue: 2024, Volume 10 - Issue 1
9091
3293
Genetically engineered mice models and generating glioblastoma multiforme in the brain
Yasin Polat, Oytun Erbaş
DOI: 10.5606/fng.btd.2024.147
Issue: 2024, Volume 10 - Issue 1
5104
3310
Ferroptosis-related gene regulation and miRNA/lncRNA Network on Temozolomide Resistance in Glioblastoma
Ece Gumusoglu-Acar, Tuba Gunel
DOI: 10.5606/fng.btd.2025.210
Issue: 2025, Volume 11 - Issue 3
2299
1572